Abstract
Somatostatin inhibits gastroenteropancreatic exocrine secretion and is often used after pancreaticoduodenectomy to reduce pancreatic secretion to minimize tissue damage and pancreatic stump complications. Because our earlier clinical work saw a major increase in delayed gastric emptying (DGE) with somatostatin prophylaxis after pylorus-preserving pancreaticoduodenectomy (PPPD), this small-group study was designed to confirm or disprove that observation. From August 1997 to December 2000, a total of 23 post-PPPD patients were randomized to receive somatostatin prophylaxis [somatostain (+)] (n = 11) or not [somatostatin] (−) (n = 12). The incidence of DGE, scintographic solid-phase emptying results on day 14 postoperatively, and sequential fasting plasma motilin levels were compared, as motilin levels are related to both gastric motility and somatostatin levels. The somatostatin(+) group exhibited greatly increased patient complaints of DGE: 9 of 11 (82%) versus 3 of 12 (25%) in the somatostatin(−) group. Radiologic scintography showed somatostatin prophylaxis prolonged the half-time (T1/2) of solid-phase emptying: 144.5 ± 51.4 minutes for somatostatin(+) versus 89.0 ± 59.9 minutes for somatostatin(−) (p < 0.001). Comparing pre-PPPD and post-PPPD plasma motilin levels prior to somatostatin infusion, motilin decreased 80% in reaction to the surgery. For somatostatin(−) patients, motilin levels oscillated, or “rang,” postoperatively, reaching a higher level on day 3, declined to a new record minimum on day 7, and by day 21 were 50% of the original and the slope of the recovery curve was increasing well. In somatostatin(+) patients the same ringing pattern was observed but decreased with motilin levels 30% to 70% lower than in the somatostatin(−) patients. By day 21 somatostatin(+) motilin levels were recovering but still only 20% original levels, and the slope of the recovery curve was not optimistic. On postoperative day 14 the plasma motilin levels (below approximately 6 bg/ml) correlated strongly with DGE for both groups. Despite the small sample size, the results indicated that (1) somatostatin prophylaxis significantly decreases fasting plasma motilin; (2) somatostatin prophylaxis produces lingering suppression of plasma motilin; (3) PPPD surgery itself significantly reduces fasting motilin levels with recovery to 50% normal at day 21; (4) the mechanism of somatostatin-induced DGE seems related to reduced fasting plasma motilin levels.
Similar content being viewed by others
References
Whipple AO. The rational for cancer of the pancreas and ampullary region. Ann. Surg. 1941;114:612–615
Watson K. Carcinoma of the ampulla of Vater: successful radical resection. Br. J. Surg. 1944;31:368–373
Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality and survival after the Whipple procedure. Ann. Surg. 1987;206:358–365
Fish JC, Smith LB, William RD. Digestive function after radical pancreaticoduodenectomy. Am. J. Surg. 1969;117:40–45
Traverso LW, Longmire WP Jr. Preservation of the pylorus in pancreaticoduodenectomy. Surg. Genecol. Obstet. 1978;146:959–962
Braasch LW, Rossi RL, Watkins E Jr, et al. Pyloric and gastric preserving pancreatic resection: experience with 87 patients. Ann. Surg. 1986;204:411–418
McAfee MK, Van Heerden JA, Adson MA. Is proximal pancreaticoduodenectomy with pyloric preservation superior to total pancreatectomy. Surgery 1989;125:347–351
Grace PA, Pitt HA, Longmire WP. Pylorus-preserving pancreaticoduodenectomy; an overview. Br. J. Surg. 1990;77:968–974
Lin PW, Lin YJ. Prospective randomized comparison between pylorus-preserving pancreaticoduodenectomy. Br. J.Surg.1999; 86:603–607
Hunt DR, Mclean R. Pylorus-preserving pancreatectomy: functional results. Br. J. Surg. 1989;76:173–176
Sadowski C, Uhl W, Baer HU, et al. Delayed gastric emptying after classic and pylorus-preserving whipple procedure: a prospective study. Dig. Surg. 1997;14:159–164
Rapits S, Schlegel W, Lehmann E, et al. Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones. Metabolism 1978;27:1321–1328
Buchler M, Friess H, Klempa I, et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am. J. Surg. 1992;163:125–131
Montorsi M, Zago M, Mosca F, et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resection: a prospective controlled randomized clinical trial. Surgery 1995;117:26–31
Shan YS, Sy ED, Lin PW. Role of somatostatin in the prevention of pancreatic stump related morbidity following elective pancreaticoduodenectomy in high risk patients and elimination of surgeon elated factor: a prospective, randomized, controlled trial. World J. Surg. 2003;27:709–714
Shan YS, Tsai ML, Chiu NT, Lin PW. Reconsideration of Delayed gastric emptying in pancreaticoduodenectomy. World J. Surg. 2005 29: 873–879
Ho LT, Chen RL, Chou TY, et al. Pharmacokinetics and effects of intravenous infusion of somatostatin in normal subjects—a two-compartment open model. Clin. Physiol. Biochem. 1986;4:257–267
Thor PJ, Matyja A, Popiela T, et al. Early effects of standard and pylorus-preserving pancreaticoduodenectmy on myoelectric activity and gastric emptying. Hepatogastroenterology 1999;46:1963–1967
Bloom SR, Mitznegg P, Bryant MG. Measurement of human plasma motilin. Scand. J. Gastroenterol. 1976;11(Suppl.39):47–52
Lin PW, Lee JC, Lee PC, et al. A simple, secure, and universal pancreaticojejunostomy following pancreaticoduodenectomy. HPB Surg. 1997;10:305–310
Peeters TL, Janseens J, Vantrappen GR. Somatostatin and the interdigestive migrating motor complex in man. Regul. Peptide. 1983;5:209–217
Peeters TL, Vantrappen G, Janssens J. Fasting plasma motilin levels are related to the interdigestive motility complex. Gastroenterology 1980;79:716–719
Chen JD, Lin ZY, Edmunds MC III, et al. Effects of octreotide and erythromycin on gastric myoelectrical and motor activities in patients with gastropresis. Dig. Dis. Sci. 1998;43:80–89
Labo G, Bortolotti M, Vezzadini P, et al. Interdigestive gastroduodenal motility and serum motilin levels in patients with idiopathic delay in gastric emptying. Gastroenterology 1986;90:20–26
Lee KY, Chang TM, Chey WY. Effect of rabbit antimotilin serum on myoelectric activity and plasma motilin concentration in fasting dog. Am. J Physiol. 1983;245:G547–G553
Nelson DK, Pieramico O, Dahmen G, et al. M1-muscarinic mechanisms regulate interdigestive cycling of motor and secretory activity in human upper gut. Dig. Dis. Sci. 1996;41:2006–2015
Modlin IM, Mitznegg P, Bloom SR. Motilin release in the pig. Gut 1978;19:399–402
Yeo CJ, Barrry MK, Sauter PK, et al. Erythromycin accelerates gastric emptying after pancreaticoduodenectomy: a prospective, randomized, placebo-controlled trial. Ann. Surg. 1993;218:229–238
Matsunaga H, Tanaka M, Naritomi G, et al. Effect of leucine 13-motilin (KW5139) on early gastric stasis after pylorus-preserving pancreaticoduodenectomy. Ann. Surg. 1998;227:507–512
Ohwada S, Satoh Y, Kawate S, et al. Low-dose erythromycin reduces delayed gastric emptying and improves gastric motility after Billroth I pylorus-preserving pancreaticoduodenectomy. Ann. Surg. 2001;234:668–674
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shan, YS., Sy, E.D., Tsai, ML. et al. Effects of Somatostatin Prophylaxis after Pylorus-preserving Pancreaticoduodenectomy: Increased Delayed Gastric Emptying and Reduced Plasma Motilin. World J. Surg. 29, 1319–1324 (2005). https://doi.org/10.1007/s00268-005-7943-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-005-7943-5